About > Leadership
Jennifer Chan, MD
Contact
Jennifer Chan, MD
Director of the Arnie Charbonneau Cancer Institute and an Associate Professor in the Department of Pathology & Laboratory Medicine, at the University of Calgary

Director of the Arnie Charbonneau Cancer Institute, University of Calgary

Director of the Arnie Charbonneau Cancer Institute and an Associate Professor in the Department of Pathology & Laboratory Medicine, at the University of Calgary
Director of the Arnie Charbonneau Cancer Institute, University of Calgary

Dr. Jennifer Chan is the Director of the Arnie Charbonneau Cancer Institute at the University of Calgary and the Consortium Leader of the Prairie Cancer Research Consortium in the Marathon of Hope Cancer Centres Network. As a pathologist-scientist and research leader with over 14 years of experience, Dr. Chan‘s ability to traverse between the lab and the clinic has enabled her to bring together investigators from across the cancer research continuum. She has led, co-led, and contributed to projects to discover new genes and therapeutic targets in a range of cancers (with particular interest in brain tumours) through her expertise in tissue histopathologic and molecular analysis, biologic correlates of clinical studies, biobanking, and patient-derived model generation.  She currently directs the Clark Smith Tumour Bank at the University of Calgary, is a principal investigator of the Alberta Cancer Research Biobank, serves on Canadian Tissue Repository Network’s College of Advisors, and is a member of the Correlative Sciences and Tumour Biology Committee of the Canadian Cancer Trials Group. Previously, she was the Pathology Leader at the Broad Institute’s Biological Samples Platform.

Dr. Chan earned a bachelor’s degree in Biochemistry and Molecular Biology from Dartmouth College, an MD from McGill University, and completed her clinical training in Anatomic Pathology and Neuropathology at Brigham and Women’s Hospital and Children’s Hospital Boston. She completed her research training at Harvard Medical School and the Dana-Farber Cancer Institute.